Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Catabasis Pharmaceuticals, Inc.

TRADE

NASDAQ: CATBHealthcare / Biotechnology / USA
0.70+0.01+1.45%Vol 540 8911Y Perf -70.67%
Oct 19th, 2018 16:00
BID0.67 ASK0.71
Open0.70 Previous Close0.69
Pre-Market0.70 After-Trading0.68
 0.01 1.45%  -0.02 -2.86%
Target Price
3.83 
Analyst Rating
Strong Buy 1.00
Potencial %
447.14 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)50 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
5.08 
Earnings Date
8th Nov 2018

Today's Price Range

0.680.72

 

52wk Range

0.612.38

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
-15.66%
3 Months
-6.67%
6 Months
-57.83%
1 Year
-70.67%
3 Years
-91.11%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
CATB0.700.01001.45
AAPL219.313.29001.52
GOOG1 096.468.49000.78
MSFT108.660.16000.15
XOM81.970.12000.15
WFC52.89-0.2100-0.40
JNJ139.05-0.4500-0.32
FB154.05-0.8700-0.56
GE12.560.18001.45
JPM107.91-0.1800-0.17
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 10.10
Current Ratio 10.20
Long Term Debt to Total Capital 0.04
Total Debt to Equity 0.02
Interest Coverage -95.50
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-5 273.80
EBITDA Margin-5 225.00
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.12
PS Ratios 204.59
Price to Cash Flow -
Price to Free Cash Flow -2.80
Cash Flow Per Share -0.97
Price to Tangible Book1.12
Book Value per Share0.64
Enterprise Value (in ths.)2 048
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)823.93
ROE last 12 Months -78.54
Return on Assets (5Y Avg) -67.18
ROA last 12 Months -64.70
Return on Capital (5Y Avg) -
ROC last 12 Months -73.79
Return on invested Capital Q -21.05
Return on invested Capital Y-116.15
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)250
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.27-0.2025.93
Q01 2018-0.23-0.29-26.09
Q04 2017-0.31-0.2422.58
Q03 2017-0.34-0.318.82
Q02 2017-0.39-0.3217.95
Q01 2017-0.45-0.418.89
Q04 2016-0.49-0.474.08
Q03 2016-0.65-0.5416.92
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.1633.33Positive
12/2018 QR-0.1636.00Positive
12/2018 FY-0.7527.88Positive
12/2019 FY-0.6757.05Positive
Next Report Date8th Nov 2018
Estimated EPS Next Report-0.16
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume540 891
Shares Outstanding (in ths.)71 040
Trades Count898
Dollar Volume374 216
Avg. Volume879 046
Avg. Weekly Volume1 188 080
Avg. Monthly Volume1 257 825
Avg. Quarterly Volume1 083 580

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

58%42%

Bearish Bullish

33%67%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x